Status:
UNKNOWN
Alendronate in the Prevention of Collapse of Femoral Head in Non-Traumatic Osteonecrosis
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital
Collaborating Sponsors:
Merck Sharp & Dohme LLC
National Cheng-Kung University Hospital
Conditions:
Non-Traumatic Osteonecrosis
Eligibility:
All Genders
20-85 years
Phase:
PHASE4
Brief Summary
To determine the cumulative incidence of total hip replacement, time to event after treatment with Fosamax or placebo during the study peroid
Detailed Description
To determine the cumulative incidence of total hip replacement and collpase of femoral head, time to event after treatment with Fosamax or placebo during the study peroid
Eligibility Criteria
Inclusion
- osteonecrosis of femoral head
- be able to provide singed informed consent
Exclusion
- prior bisphosphonate use
- pregnant or lactating woman
- bilateral hip replacement
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
End Date :
June 1 2008
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00265252
Start Date
June 1 2005
End Date
June 1 2008
Last Update
February 27 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan, 807